MOUNTAIN VIEW, Calif., April 29, 2014 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that it will report financial results for the first quarter ended March 31, 2014 after the NASDAQ Market closes on Monday, May 5, 2014. The company will conduct a conference call and an audio webcast at 4:30pm EDT the same day.
Date: May 5, 2014
Time: 4:30 PM ET

Listen via Internet: Schedule this webcast into MS-Outlook calendar (click open when prompted):
Toll-free:  (877) 359-2916
International: +(224) 357-2386

A webcast replay will be available on the VIVUS website for 30 days.

VIVUS is a biopharmaceutical company commercializing Qsymia(r) (phentermine and topiramate extended-release) capsules CIV for the treatment of obesity. For more information about the company, please visit

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe", "estimate," "expect," "forecast," "intend," "likely," "may," "opportunity," "plan," "potential," "predict," and "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in the VIVUS Form 10-K for the year ending December 31, 2013, and periodic reports filed with the Securities and Exchange Commission.
CONTACT: VIVUS, Inc.         Dana B. Shinbaum (Corporate Development & Investor Relations)         650-934-5200         The Trout Group         Brian Korb (Senior Vice President)         646-378-2923

VIVUS logo